StockGlow

Onconetix, Inc. (ONCO)

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union.

$0.77-0.02%Healthcare
Compare ONCO with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-99.6%

The outlook

Onconetix, Inc. currently reads as bearish based on below its 50- & 200-day averages, 0% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$2.8M
52-wk high
$209.50
52-wk low
$0.67
50-day avg
$1.00
200-day avg
$54.62
Trailing P/E
0.0

Similar stocks

NIVFNewGenIvf Group Limited$0.84-0.88%AZTRAzitra, Inc.$0.13+0.69%ATPCAgape ATP Corporation$2.35+0.00%TRNRInteractive Strength Inc.$2.91-2.35%PBMPsyence Biomedical Ltd.$3.17-5.65%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy